Evidence map›Paper›PMID 35305823›Full record

ArticleVaccine2022

COVID-19 vaccine intention among young adults: Comparative results from a cross-sectional study in Canada and France.

Pierre-Julien Coulaud, Aidan Ablona, Naseeb Bolduc, Danya Fast, Karine Bertrand, Jeremy K Ward, Devon Greyson, Marie Jauffret-Roustide, Rod Knight

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. 'Is It Safe? Is it not?' A Youth-Led Photovoice Study of Youth Perspectives of COVID-19 Vaccine Confidence.Health expectations : an international journal of public participation in health care and health policy · 2024
    Article
  4. Article
  5. COVID-19 vaccine uptake among young adults: Influence of asthma and sociodemographic factors.The journal of allergy and clinical immunology. Global · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 3 countries.

Pierre-Julien CoulaudBritish Columbia Centre on Substance Use, Vancouver, British Columbia, Canada; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: pierre-julien.coulaud@bccsu.ubc.ca.
Aidan AblonaBritish Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Naseeb BolducBritish Columbia Centre on Substance Use, Vancouver, British Columbia, Canada; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Danya FastBritish Columbia Centre on Substance Use, Vancouver, British Columbia, Canada; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Karine BertrandFaculty of Medicine and Health Sciences, Université de Sherbrooke, Longueuil, Québec, Canada.
Jeremy K WardCERMES3 (Inserm U988/CNRS UMR8211/EHESS/Université de Paris) Paris, France; Aix-Marseille Université, IRD, AP-HM, SSA, VITROME, Marseille, France.
Devon GreysonSchool of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada; University of Massachusetts-Amherst, Amherst, MA, USA.
Marie Jauffret-RoustideBritish Columbia Centre on Substance Use, Vancouver, British Columbia, Canada; Centre d'Étude des Mouvements Sociaux (EHESS/CNRS UMR8044/INSERM U1276), Paris, France; Baldy Center on Law and Social Policy, Buffalo University, NY, USA.
Rod KnightBritish Columbia Centre on Substance Use, Vancouver, British Columbia, Canada; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
University of British Columbia · CABC Centre for Disease Control · CABritish Columbia Centre on Substance Use · CACentre de Recherche Médecine, Sciences, Santé, Santé Mentale, Société · FRCentre de Recherche sur les Liens Sociaux · FRUniversité de Sherbrooke · CAUniversity of Massachusetts Amherst · US

Funding

CIHR VR5 172673
6 · The paper itself

Abstract

backgroundHigh rates of COVID-19 vaccination uptake are required to attain community immunity. This study aims to identify factors associated with COVID-19 vaccine uncertainty and refusal among young adults, an underexplored population with regards to vaccine intention generally, in two high-income settings: Canada and France.

methodsA cross-sectional online survey was conducted from October to December 2020 among young adults ages 18-29 years (n = 6663) living in Canada (51.9%) and France (48.1%). Multinomial logistic regression analyses were performed to identify the sociodemographic and COVID-19-related measures (e.g., prevention behavior and perspectives, health-related concerns) associated with vaccine uncertainty and refusal. We conducted weighted analyses by age, gender and province/region of residence.

resultsIntention to accept vaccination was reported by 84.3% and 59.7% of the sample in Canada and France, respectively. Higher levels of vaccine uncertainty and refusal were observed in France compared to Canada (30.1% versus 11%, 10.2% versus 4.7%). In both countries, we found higher levels of vaccine acceptance among young adults who reported COVID-19 prevention actions. Vaccine uncertainty and refusal were associated with living in a rural area, having lower levels of educational attainment, not looking for information about COVID-19, not wearing a face mask, and reporting a lower level of concern for COVID-19's impact on family. Participants who had been tested for COVID-19 were less likely to intend to refuse a vaccine.

conclusionsCOVID-19 vaccine acceptance was high among young adults in Canada and France during a time in which vaccines were approved for use. Targeted interventions to build confidence in demographic groups with greater hesitance (e.g., rural and with less personal experience with COVID-19) may further boost acceptance and improve equity as vaccine efforts continue to unfold.

Indexed as

COVID-19COVID-19 VaccinesAdolescentAdultCanadaCross-Sectional StudiesHumansIntentionSARS-CoV-2VaccinationYoung AdultCOVID-19 VaccinesCOVID-19Preventive measuresVaccinationYoung adults

Identifiers

PMID35305823
PMCPMC8890971
OpenAlexW4214891758

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.